Accurate Answers With Full Confidence
The HemoCue Glucose 201 DM RT system puts labequivalent answers in health professionals’ hands when they’re needed most — at the point of care. Not only does the unique cuvette technology enable the highest accuracy in just three simple steps, but it reduces serious contamination risks.This handheld and battery-operated system with room temperature microcuvette storage, ideal for mobile settings
HemoCue Glucose 201 DM RT Systems
The correct volume of sample is drawn into the microcuvette by capillary action, it is spontaneously mixed with the reagents in the cuvette cavity. This gives the advantage that no mixing of reagents, dispensing or pipetting is required.
The systems are available in two measuring units g/dL or mmol/L and for blood or plasma. Conversion between this units can also be calcluated with a conversion calculator.
Measure in 3 simple steps
HemoCue is a global leader in a field of diagnostics known as near patient, or point-of-care, testing. In 1982, HemoCue AB, based in Ängelholm, Sweden, introduced the first system making accurate hemoglobin testing possible in near-patient settings. Since then, more than 350,000 HemoCue systems have been sold worldwide. The company also sells point-of-care tests for glucose, urine albumin, HbA1c, total and differential white blood cell count.